Tretinoin While Traveling: How to Keep Your Skin Routine on the Road
What the Renova 0.02% tretinoin cream label says about evening use, sun exposure, sunscreen and irritation, for people who are traveling.
What the Renova 0.02% tretinoin cream label says about evening use, sun exposure, sunscreen and irritation, for people who are traveling.
Can you exercise on vaginal estradiol? Learn how local estrogen therapy interacts with physical activity, what the research says, and practical tips for living well with vaginal estradiol.
How vardenafil affects relationships, emotional intimacy, partner satisfaction, and daily life. Covers real-world evidence, patient-reported outcomes, dosing context, and practical guidance for couples.
A practical guide to traveling with sildenafil (Viagra): airport security, time-zone dosing, altitude effects, food and alcohol interactions, and how to store your medication safely abroad.
How Vyvanse (lisdexamfetamine) affects focus, productivity, side effects, and workplace disclosure. Evidence-based guidance on dosing timing, diet, and legal rights for adults with ADHD or binge eating disorder.
Wegovy works without exercise, but resistance training helps preserve muscle while you lose fat. Here's what changes with workouts and fueling on semaglutide.
FDA's black-box warning on zolpidem states that alcohol and other CNS depressants may cause profound sedation, respiratory depression, coma, and death.
A deep dive into how liothyronine (T3) affects appetite, hunger signaling, and food cravings. Covers the physiology, clinical evidence, dosing context, and when to contact your prescriber.
What happens when you stop taking liothyronine (Cytomel)? Learn the physiology of T3 rebound, TSH overshoot, symptom timeline, and how to taper safely with guidance from primary literature.
A clinical deep-dive into how liothyronine (Cytomel, T3) affects sleep architecture, REM cycles, slow-wave sleep, and practical dosing strategies to protect sleep quality during thyroid hormone therapy.
A complete clinical guide to monitoring liraglutide in adults aged 30 to 49, covering labs, vitals, GI tolerance, dose titration checkpoints, and red-flag signs that require urgent review.
A comprehensive clinical review of liraglutide for metabolic syndrome, covering FDA approval status, SCALE trial evidence, dosing protocols, side-effect management, and coverage options for patients with the condition.
A guide to liraglutide dosing in adults 65 and older, covering titration schedules, renal and hepatic adjustments, fall risk, polypharmacy, and deprescribing.
A clinically detailed review of liraglutide safety for adults ages 50 to 64, covering cardiovascular outcomes, GI tolerability, hypoglycemia risk, polypharmacy interactions, and perimenopause or andropause overlap. Based on SCALE Obesity, LEADER, and current ADA and Endocrine Society guidelines.
A comprehensive guide to holding liraglutide before surgery, covering aspiration risk, GLP-1 gastroparesis effects, current anesthesia society guidelines, and resumption timing.
A deep dive into how liraglutide affects sexual function in men and women, covering weight-loss mechanisms, hormonal changes, trial data, and practical clinical guidance.
Combining ACE inhibitors and ARBs isn't standard care. See lisinopril's real risks: cough, angioedema, pregnancy dangers, and dosing for ages 30 to 49.
A physician-reviewed, evidence-based guide to every clinically significant lisinopril drug interaction, including potassium-sparing diuretics, NSAIDs, ARBs, lithium, and more. Covers mechanisms, magnitudes, and management.
What the lisinopril label lists for hair and skin, including alopecia, photosensitivity and psoriasis, and why angioedema needs urgent attention.
A clinical review of how lisinopril affects mood, cognition, depression, anxiety, and quality of life, with primary-literature citations and prescribing guidance from the HealthRX.com medical team.
GLP-1 receptor agonists, especially semaglutide and tirzepatide, have produced meaningful MASH resolution rates in randomized trials. Here is what is established, what is still evolving, and how to think about eligibility.
A detailed breakdown of resmetirom (Rezdiffra) costs in 2026, including list price, insurance coverage, patient assistance programs, and how to reduce out-of-pocket spending for MASLD/MASH treatment.
Lean MASLD affects people with a normal BMI but still causes significant liver damage. Learn who is at risk, how it differs from obesity-related MASLD, and what treatment options exist.
A guide to SGLT2 inhibitors for MASLD, MASH, and liver fibrosis, comparing empagliflozin, dapagliflozin, and canagliflozin against pioglitazone, vitamin E, obeticholic acid, and resmetirom.
A detailed guide to Blue Cross of Idaho metformin coverage, including formulary tiers, prior authorization rules, cost-sharing, and how to get metformin for as little as $0/month.
What is actually known about Presbyterian Healthcare Services (PHS) metformin coverage, what varies by plan year and cannot be confirmed from public sources, and how to verify your specific formulary tier, prior authorization rules, and cost before you fill a prescription.
A guide to longevity medicine for athletes over 40 and 50, covering TRT, GLP-1s, HGH peptides, HRT, cognitive protection, and dementia risk reduction backed by named trials and guidelines.
A breakdown of berberine's longevity evidence alongside rapamycin, metformin, NR, and NMN. Real trial data, doses, and clinical context.
A deep dive into cellular senescence, the biology of zombie cells, their role in frailty, sarcopenia, and mitochondrial dysfunction, plus the current evidence on senolytic and senomorphic interventions.
Off-label metformin prescribing for healthy adults as an anti-aging intervention rests on thin human evidence. The HealthRX.com Medical Team argues that until TAME reports, prescribing should follow metabolic indications, not a generalized aging signal.
A guide to long-term metformin safety, covering lactic acidosis risk, B12 depletion, kidney thresholds, rapamycin monitoring, and senolytic trial signals.
A look at low-dose lithium, rapamycin, metformin, NR, and NMN as longevity agents. Covers mechanisms, doses, trial data, and safety considerations.
Mitochondrial dysfunction drives biological aging, frailty, sarcopenia, and cellular senescence. Learn the mechanisms, biomarkers, and evidence-based interventions clinicians use to slow or partially reverse mitochondrial decline.
Human trials tested NMN at 250 to 1,250 mg a day. Blood NAD+ rose, but no dose has an established clinical benefit, and safety data run about 12 weeks.
A guide to NMN and NR dosing, weekly rapamycin protocols, and off-label metformin dosing for longevity, with trial data and specific dose ranges for each compound.
A guide to rapamycin, metformin, NR, NMN, and glucosamine as longevity interventions, mechanisms, trial data, doses, and clinical decision points.
Sarcopenia is the age-related loss of skeletal muscle mass and strength that drives frailty, falls, and early death. Learn what causes it, how it is diagnosed, and which interventions actually work.
A deep dive into whether SGLT2 inhibitors like empagliflozin and dapagliflozin extend healthspan, how they compare to rapamycin, metformin, NR, and NMN, and what the current evidence supports for off-label longevity use.
Does losartan affect appetite or food cravings? An evidence-based analysis of losartan's metabolic effects, the LIFE trial, RAAS-appetite links, and what patients should expect.
Combining losartan with spironolactone raises hyperkalemia risk via dual RAAS blockade; pharmacists should monitor serum potassium and renal function closely.
A guide to losartan's safety profile during pregnancy and breastfeeding, covering mechanisms, trimester-specific risks, alternative agents, and FDA/ACOG guidance.
A guide to losartan storage conditions, chemical stability, shelf life, and what happens when tablets are exposed to heat, humidity, or light. Includes mechanism of action, key trial data, and FDA-cited evidence.
A guide to how low-dose naltrexone (LDN) affects appetite, food cravings, and body weight, with primary-literature citations, dosing context, and practical guidance.
An evidence-based look at how low-dose naltrexone (LDN) affects bone density, osteoclast activity, and fracture risk, with primary-literature citations throughout.
An evidence-based breakdown of how low-dose naltrexone (LDN) affects cognitive function, brain fog, neuroinflammation, and mental clarity, including trial data, mechanisms, dosing, and clinical context.
A guide to compounded low-dose naltrexone dosing in adults aged 65 and older, covering starting doses, renal adjustment, fall risk, drug interactions, and deprescribing considerations.
A guide to how low-dose naltrexone (LDN) affects hair growth, hair loss, skin inflammation, and dermatologic autoimmune conditions, with primary-literature citations and dosing context.
A guide to alprostadil for erectile dysfunction, covering MUSE urethral suppositories, Caverject and Edex injections, real trial data, dosing protocols, and head-to-head comparison with sildenafil, tadalafil, vardenafil, and avanafil.
Grapefruit and grapefruit juice block the enzyme that clears sildenafil, tadalafil, and other ED medications from your body, raising plasma levels and side-effect risk. Learn which drugs are affected, by how much, and what to do instead.
Learn which antibiotics interact with Cialis (tadalafil), how to adjust your dose, how long Cialis lasts versus Viagra, and when daily tadalafil makes more sense than on-demand dosing.
A guide to erectile dysfunction covering causes, risk factors, oral medications, injection therapy, hormonal workup, and when to seek care. Includes coverage of premature ejaculation, delayed ejaculation, low libido, and Peyronie's disease.
A guide covering erectile dysfunction, testosterone therapy, and sexual function in men with heart disease, diabetes, BPH, TRT use, and after prostatectomy. Includes dosing, trial data, and safety guidance.
What sildenafil and tadalafil labels say about sudden vision loss, what observational studies can and cannot prove about NAION, and when to seek urgent eye care.
Post-SSRI sexual dysfunction (PSSD) can persist for months or years after stopping antidepressants. Learn what causes it, how to recognize it, and the evidence-based treatments available in 2025.
A detailed clinical comparison of sildenafil (Viagra) and vardenafil (Levitra) covering onset, duration, dosing, side effects, drug interactions, and how each stacks up against tadalafil, avanafil, PT-141, and Trimix.
A guide to trimix injection site complications, including priapism, fibrosis, hematoma, and infection, with specific prevention protocols and emergency steps.
Learn how 5-alpha reductase converts testosterone to dihydrotestosterone (DHT), what that means for hair loss, prostate health, and libido, and how free vs total testosterone levels factor into TRT decisions.
Bioavailable testosterone is the fraction your tissues can actually use. Learn how SHBG binds testosterone, how to calculate free vs. bioavailable T, what suppresses the HPG axis, and when TRT is warranted.
How to interpret a complete blood count on testosterone replacement therapy, including hematocrit thresholds, erythrocytosis risk, and how CBC fits with testosterone, estradiol, and lipid monitoring. Pending qualified medical review.
A rigorous cross-trial synthesis of the Testosterone Trials (Snyder 2016) and TRAVERSE (Lincoff 2023), covering functional benefits, cardiovascular safety, atrial fibrillation, fracture risk, and prostate signals, matched column by column.